MR1 and breast carcinoma: Thus, MR1-restricted TCRs derived from the TILs of breast cancer patients reacted to an antigen expressed in MCF7 or MDA-MB-231 breast cancer cells but not expressed in other cancer cell lines, including the ZR-75-1 breast cancer cell line.